The article's table rates hypoglycemia risk as low to minimal when a DPP-4 inhibitor is added to a GLP-1 agonist, and says studies showed no increase versus monotherapy, used with or without metformin
This is why if they do the peptides, they need CJC w DAC
GLP-1 medications can cause side effects ranging from mild nausea to severe complications like pancreatitis or kidney problems
While ecnoglutide has not yet received formal marketing authorization for any indication in any country or region worldwide, in China, new drug applications (NDAs) are under review
Join Euro Reproduction, Fertility and Gynecology Conference Istanbul, Turkey - SEP 21-22: Join Fertility, Gynecology and Womens Health Conference Abu Dhabi, UAE - NOV 23-24: Join Explore our AZ list of leading Pharma, Biotech & Life Science LinkedIn groups from worldwide networks to focused communities built for professionals like you